When Can We Avoid Postmastectomy Radiation Following Primary Systemic Therapy?-Reference-Cited by-同舟云学术

When Can We Avoid Postmastectomy Radiation Following Primary Systemic Therapy?

Published:2019-10-29 Issue:11 Volume:21 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Montero Ángel,Ciérvide Raquel,Poortmans Philip

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-019-0850-y.pdf

Reference58 articles.

1. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97(2):116–26.

2. Overgaard M, Hansen PS, Overgaard J, Carsten R, Andersson M, Bah F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–55.

3. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–8.

4. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82(3):247–53.

5. Li Y, Moran MS, Huo Q, Yang Q, Haffty BG. Post-mastectomy radiotherapy for breast cancer patients with T1-T2 and 1-3 positive lymph nodes: a meta-analysis. PLoS One. 2013;8(12):1–9.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escalation and De-Escalation of Adjuvant Radiotherapy in Early Breast Cancer: Strategies for Risk-Adapted Optimization;Cancers;2024-08-23

2. Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review;Discover Nano;2024-08-03

3. Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future;La radiologia medica;2023-11-03

4. Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures;The Breast;2023-06

5. Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer;JAMA Oncology;2022-04-01